Effect of formulation and processing variables on the particle size of sorbitan monopalmitate niosomes

In the last two decades, there was an extensive research focused on the study of synthetic amphiphilic vesicles, prepared by nonionic surfactants (niosomes). The particle size of these vesicles is critical for their intended therapeutic benefits. Formulation and processing factors affect greatly the physical characteristics of the resulted nanosystems. Therefore, the present work was adopted to investigate how proper manipulation of various formulations and processing factors on vesicular Z-average particle size. The selected variables were membrane additives, [including cholesterol (CHO), dicetylphosphate (DCP) and stearylamine (SA)], sonication time as well as drug loading factor (using mannitol and estradiol). Sorbitan monopalmitate (span 40) niosomes were prepared by the conventional thin film hydration method. Particle size, measured by Photon Correlation Spectroscopy, and polydispersity indices were measured and compared.The results indicated that CHO increased the vesicular size, with 2:1 and 1:1 (span 40:CHO) ratios showing the same size. Sonication reduced the vesicle size by 23, 35 and 42% after 10, 20 and 30 min, respectively. After 30 min, the effect of sonication was minor. The addition of charge inducing agents changed the zeta potential depending on the type of the additives. Surface charge increased the size by 24 and 11% when using DCP and SA, respectively. Drug incorporation increased the vesicle size to an extent based on its aqueous solubility. There were about 35 and 6.2% increase in vesicular size for estradiol and mannitol, respectively, supporting the partitioning of lipophilic drug within the fatty acyl side chains of the bilayer membrane.

[1]  S. Koda,et al.  Effects of frequency and power of ultrasound on the size reduction of liposome. , 2009, Chemistry and physics of lipids.

[2]  V. Junyaprasert,et al.  Effect of Charged and Non-ionic Membrane Additives on Physicochemical Properties and Stability of Niosomes , 2008, AAPS PharmSciTech.

[3]  W. Pitt,et al.  The role of cavitation in liposome formation. , 2007, Biophysical journal.

[4]  Jean-Claude Voegel,et al.  Coating of negatively charged liposomes by polylysine: drug release study. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[5]  A. Pardakhty,et al.  In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. , 2007, International journal of pharmaceutics.

[6]  Y. Pei,et al.  Stealth PEG-PHDCA niosomes: effects of chain length of PEG and particle size on niosomes surface properties, in vitro drug release, phagocytic uptake, in vivo pharmacokinetics and antitumor activity. , 2006, Journal of pharmaceutical sciences.

[7]  H. Maibach,et al.  Liposomes and Niosomes as Topical Drug Delivery Systems , 2005, Skin Pharmacology and Physiology.

[8]  M. L. González-Rodríguez,et al.  Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes. , 2005, International journal of pharmaceutics.

[9]  O. Katare,et al.  Liposomal drug delivery systems--clinical applications. , 2005, Acta pharmaceutica.

[10]  S. Lim,et al.  The Effect of Cholesterol in the Liposome Bilayer on the Stabilization of Incorporated Retinol , 2005, Journal of liposome research.

[11]  P. Couvreur,et al.  Liposomes and Nanoparticles in the Treatment of Intracellular Bacterial Infections , 1991, Pharmaceutical Research.

[12]  A. Mitra,et al.  Effects of Phospholipid Chain Length, Concentration, Charge, and Vesicle Size on Pulmonary Insulin Absorption , 2004, Pharmaceutical Research.

[13]  S. Takeuchi,et al.  Evaluation of the Hardness of Lipid Bilayer Membranes of Liposomes by the Ultrasound Attenuation Method , 2003 .

[14]  M. Dellian,et al.  Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels , 2003, International journal of cancer.

[15]  A. Fahra,et al.  Particle size of liposomes influences dermal delivery of substances into skin , 2003 .

[16]  I. Ahmad,et al.  Liposomes (a review). Part two: Drug delivery systems , 2002 .

[17]  Y. Y. Wang,et al.  Effect of liposomes and niosomes on skin permeation of enoxacin. , 2001, International journal of pharmaceutics.

[18]  Venkatesh,et al.  Niosomal Sumartriptan Succinate For Nasal Administration , 2000 .

[19]  J. Kristl,et al.  Liposomes as a topical delivery system: the role of size on transport studied by the EPR imaging method. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[20]  Ijeoma F. Uchegbu,et al.  Non-ionic surfactant based vesicles (niosomes) in drug delivery , 1998 .

[21]  M. Carafa,et al.  Preparation and properties of new unilamellar non-ionic/ionic surfactant vesicles , 1998 .

[22]  F. Bonina,et al.  In vitro retinoic acid release and skin permeation from different liposome formulations , 1996 .

[23]  I. Uchegbu,et al.  Non-ionic surfactant vesicles (niosomes): Physical and pharmaceutical chemistry , 1995 .

[24]  C. Brennen.  Cavitation and Bubble Dynamics , 1995 .

[25]  D. Lasič.  Mechanisms of Liposome Formation , 1995 .

[26]  H. Kiwada,et al.  Effects of fluidity and vesicle size on antitumor activity and myelosuppressive activity of liposomes loaded with daunorubicin. , 1994, Biological & pharmaceutical bulletin.

[27]  N. Van Rooijen,et al.  Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. , 1994, Biochimica et biophysica acta.

[28]  J. Bouwstra,et al.  LARGE DISK-SHAPED STRUCTURES (DISCOMES) IN NONIONIC SURFACTANT VESICLE TO MICELLE TRANSITIONS , 1992 .

[29]  D Needham,et al.  Elastic deformation and failure of lipid bilayer membranes containing cholesterol. , 1990, Biophysical journal.

[30]  H. Junginger,et al.  Niosomes: A study of structure, stability, drug release and toxicological aspects , 1990 .

[31]  R. New,et al.  Liposomes : a practical approach , 1990 .

[32]  D. Lasič,et al.  The mechanism of vesicle formation. , 1988, The Biochemical journal.

[33]  F. Szoka,et al.  Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposome-intercalated amphotericin B , 1987, Antimicrobial Agents and Chemotherapy.

[34]  A. Florence,et al.  The effect of non‐ionic surfactant vesicle (niosome) entrapment on the absorption and distribution of methotrexate in mice , 1985, The Journal of pharmacy and pharmacology.

[35]  R. Schwendener,et al.  n-Alkyl-glucosides as detergents for the preparation of highly homogeneous bilayer liposomes of variable sizes ( 60-240 nm phi) applying defined rates of detergent removal by dialysis. , 1981, Biochemical and biophysical research communications.